Knowstox

Fundamentals snapshot

Ambev S.A.

ABEV · NYQ · Consumer Defensive · Beverages - Brewers

Current price

$2.66

52-week range

$2.28 - $3.45

Market cap

$41.01B

One-glance verdict

Undervalued

$7.48 our estimate vs market $2.66

Wall Street consensus: $3.20 (-57.3% lower than our fair-value estimate)

Balance sheet

Healthy

8.20x Adequate

Net cash $3.57B. Interest coverage shows how many times profit covers the interest bill.

What this company does

Ambev S.A.

Ambev is a giant beverage company that primarily sells beer and soft drinks in countries like Brazil and Canada. Their money mainly comes from selling these drinks through a huge network of distributors and stores, and this matters because it shows how well they are reaching customers with their popular brands.

Price history

How the share price has moved

—
Loading price history…

Is it cheap or expensive?

Fair value $7.48 vs current price $2.66

Wall Street consensus is the average analyst price target: $3.20 (-57.3% lower than our fair-value estimate).

Our most-likely fair value is $7.48 a share — about 181.1% above today's price of $2.66, so the stock currently looks cheap (undervalued).

undervalued

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Base

Growth 8.0% · Discount 7.2% · Terminal 2.5%

$7.48

Bear

Growth 4.0% · Discount 7.2% · Terminal 2.5%

$5.96

Bull

Growth 15.0% · Discount 7.2% · Terminal 2.5%

$11.05

Is it drowning in debt?

Healthy

Net cash $3.6B - more cash than debt. Interest coverage 8.2x.

Net debt $-3.57B
Interest coverage 8.20x

Ambev S.A.'s profit covers its interest bill about 8.2 times over. which is stronger than every peer shown here.

Healthy
Worse cushion Baseline Better cushion
ABEV BASELINE Ambev S.A.

Total debt $504.16M Interest coverage 8.20x This is the baseline the peer rows are being compared against.

Total debt $72.73B Interest coverage 4.05x -51% vs ABEV Carries about 2.0x less debt cushion than ABEV.

Total debt $10.32B Interest coverage 7.92x -3% vs ABEV Has roughly the same debt cushion as ABEV.

Total debt $22.20B Interest coverage 2.94x -64% vs ABEV Carries about 2.8x less debt cushion than ABEV.

Total debt $7.91B Interest coverage 6.58x -20% vs ABEV Carries about 1.2x less debt cushion than ABEV.

Total debt $23.09B Interest coverage 5.17x -37% vs ABEV Carries about 1.6x less debt cushion than ABEV.

What you should know

The case for and against ABEV

3 Rewards 2 Risks

Rewards

  • Returns 17.7% on equity, ahead of 60% of its peers.
  • Free cash flow was positive in 4/10 years.
  • Trades at 14.0x P/E vs peer median 17.4x (19.7% cheaper).

Risks

  • Stock trades 433.3% above its 5-year average P/E.
  • Insider ownership is only 0.0% (peer median: 0.1%).

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
14.00x
Forward P/E
12.75x
P/B
2.27x
P/S
0.46x
EV/EBITDA
0.81x
PEG ratio
1.80x

Profitability

How much profit each dollar creates

Gross margin
51.8%
Operating margin
25.7%
Net margin
17.7%
ROE
17.7%
ROA
10.3%

Health

Liquidity and balance-sheet strength

Debt / equity
0.03x
Current ratio
1.06x
Quick ratio
0.73x
Total debt
$504.16M
Total cash
$4.07B

Growth

How the business has been compounding

Revenue TTM
$16.53B
Revenue 5Y CAGR
3.4%
EPS TTM
0.19
EPS 5Y CAGR
2.1%

Cash flow

How much cash the business throws off

Operating CF TTM
$4.54B
Free CF TTM
$3.69B
FCF margin
22.3%

Dividend

Shareholder payout

Yield
5.1%
Payout ratio
74.2%
Last ex-div date
2026-09-23